- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/015 - Parvoviridae, p. ex. virus de l'aleucémie féline, parvovirus humain
Détention brevets de la classe C07K 14/015
Brevets de cette classe: 540
Historique des publications depuis 10 ans
|
1
|
12
|
8
|
20
|
20
|
27
|
17
|
36
|
49
|
47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4376 |
21 |
| University of Florida Research Foundation, Inc. | 4079 |
20 |
| The University of North Carolina at Chapel Hill | 2063 |
18 |
| The Children's Hospital of Philadelphia | 809 |
10 |
| Dyno Therapeutics, Inc. | 45 |
10 |
| Genzyme Corporation | 1309 |
9 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
9 |
| University of Massachusetts | 2256 |
9 |
| Deutsches Krebsforschungszentrum | 415 |
8 |
| Massachusetts Eye and Ear Infirmary | 388 |
8 |
| University of Iowa Research Foundation | 835 |
8 |
| The Regents of the University of California | 20268 |
7 |
| California Institute of Technology | 3989 |
7 |
| Medigene AG | 34 |
7 |
| Children's Medical Research Institute | 66 |
6 |
| Genethon | 260 |
6 |
| Ginkgo BioWorks, Inc. | 277 |
6 |
| Universite d'Evry Val D'essonne | 213 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3207 |
6 |
| 4D Molecular Therapeutics Inc. | 52 |
6 |
| Autres propriétaires | 353 |